Ikoma, Japan

Sachiko Kobayashi




Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Sachiko Kobayashi: Innovator in Pharmaceutical Chemistry

Introduction

Sachiko Kobayashi is a prominent inventor based in Ikoma, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that interact with glucocorticoid receptors. With a total of 12 patents to her name, her work has the potential to impact various therapeutic areas.

Latest Patents

Among her latest patents, Kobayashi has developed 1,2,3,4-tetrahydroquinoxaline compounds that exhibit glucocorticoid receptor binding activity. These compounds are represented by a specific formula where various substituents can be halogens, alkyl groups, or aryl groups, among others. Additionally, she has devised a method for treating diseases related to the glucocorticoid receptor, which involves administering a pharmacologically effective amount of a 1,2-dihydroquinoline compound.

Career Highlights

Kobayashi is currently employed at Santen Pharmaceutical Co., Ltd., where she continues to innovate and contribute to the field of pharmaceutical research. Her work is characterized by a strong focus on developing new therapeutic agents that can improve patient outcomes.

Collaborations

Throughout her career, Kobayashi has collaborated with notable colleagues such as Mamoru Matsuda and Toshiyuki Mori. These collaborations have further enhanced her research and development efforts in the pharmaceutical industry.

Conclusion

Sachiko Kobayashi is a trailblazer in pharmaceutical chemistry, with a strong portfolio of patents that reflect her innovative spirit. Her contributions to glucocorticoid receptor research are paving the way for new treatment options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…